Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-685dmrPhase 2Recruiting
Phase 2, randomised, double-blind trial in Facial paresthesia comparing Selegiline hydrochloride with Placebo (2 arms). Started Sep 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-685dmr.